Stockreport

ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements

ImmunoPrecise Antibodies Ltd.  (IPA) 
PDF VICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutics company, announced to [Read more]